Patents
Sitemap › C07 - Organic chemistry › C07D - Heterocyclic compounds › C07D 213 - Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members
Patents for C07D 213 - Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members (63,273)
05/2003
05/14/2003CN1418197A Piperidine and piperazine substituted N-hydroxyformamides as inhibitors of metalloproteinases
05/14/2003CN1418194A Amide compounds and use thereof
05/14/2003CN1418191A Novel thiourea derivatives and the pharmaceutical compositions containing thd same
05/14/2003CN1108295C Thiol derivatives with metallopeptidase (ACE/NEP) inhibitory activity
05/14/2003CN1108288C Benzyloxy substituted aromatics and their use as fungicides
05/14/2003CA2411691A1 New 2.5-diaminopyridine oxydation bases used to dye keratin fibres
05/13/2003US6563002 Biscyclopropanecarboxamide compounds and pharmaceutical use thereof
05/13/2003US6562842 Osteoporosis, oral diseases
05/13/2003US6562827 For the treatment of diseases in which increased calpain activity occurs such as neurodegenerative diseases or neuronal damage are caused by ischemia, trauma or mass hemorrhages
05/13/2003US6562819 Compounds for inhibition of ceramide-mediated signal transduction
05/13/2003US6562817 Suppressants of the IgE production
05/13/2003US6562811 Pyridine derivatives
05/13/2003US6562807 For prophylaxis and therapy of hyperglycemia, Type 1 diabetes, Type 2 diabetes, disorders of the lipid metabolism, such as dyslipidemia, and obesity
05/13/2003US6562080 Primary intermediates for oxidative coloration of hair
05/08/2003WO2003038508A2 Metal complex-based electron-transfer mediators in dye-sensitized solar cells
05/08/2003WO2003037891A1 Heteroaryl amines as glycogen synthase kinase 3beta inhibitors (gsk3 inhibitors)
05/08/2003WO2003037869A1 Amide derivatives as glycogen synthase kinase 3-beta inhibitors
05/08/2003WO2003037868A1 Method for producing 2-halogen-pyridine-carboxylic acid amides
05/08/2003WO2003037867A1 Processes for the manufacturing of 3-hydroxy-n,1,6-trialkyl-4-oxo-1,4-dihydropyridine-2-carboxamide
05/08/2003WO2003037866A1 Antiretroviral pyridine and quinoline derivatives
05/08/2003WO2003037865A1 Novel anticancer compounds
05/08/2003WO2003037853A1 Substituted thioacetamides
05/08/2003WO2003037333A1 Pyridine derivatives as nmda-receptor subtype blockers
05/08/2003WO2003037311A2 Method for treating retroviral infections
05/08/2003WO2003037308A2 Utilization of inhibitors of rho-kinases for stimulating nerve growth, inhibiting scar tissue formation and/or reducing a secondary lesion
05/08/2003WO2003014128A3 Tumour inhibiting cerium compounds
05/08/2003WO2001079194A9 Method for obtaining derivatives of [[(pyridil substituted)methyl]thio]benzimidazol
05/08/2003US20030088107 Process for preparing 1-(6-methylpyridin-3-yl)-2-[4-(methylsulfonyl)phenyl]ethanone
05/08/2003US20030088103 PPARgamma modulators
05/08/2003US20030087945 Sulfonylaminocarboxylic acids
05/08/2003US20030087922 Aryl substituted 2-aminopyrimidines and 2-aminopyridines
05/08/2003US20030087921 Especially trypsin-like serine proteases, such as chymotrypsin, trypsin, thrombin, plasmin and factor Xa.
05/08/2003US20030087915 Pharmaceutical compositions and methods for use
05/08/2003US20030087905 Containing a haloalkyl group: e.g., 3-((3-(3-trifluoromethoxyphenoxy) phenyl)((3-(1,1,2,2-tetrafluoroethoxy)phenyl)methyl)amino)-1,1,1-trifluoro-2-propanol
05/08/2003US20030087891 2-Amino-6-(2,4,5-substituted-phenyl)-pyridines
05/08/2003US20030087306 Methods for identifying novel multimeric agents that modulate receptors
05/08/2003US20030087151 Low melting point
05/08/2003US20030087126 Hydrocarbon compound, material for organic electroluminescent element and organic electroluminescent element
05/08/2003CA2468761A1 Novel anticancer compounds
05/08/2003CA2466424A1 Utilization of inhibitors of rho-kinases for stimulating nerve growth, inhibiting scar tissue formation and/or reducing a secondary lesion
05/08/2003CA2465305A1 Antiretroviral pyridine and quinoline derivatives
05/08/2003CA2464888A1 Pyridine derivatives as nmda-receptor subtype blockers
05/08/2003CA2464303A1 Method for treating retroviral infections
05/08/2003CA2463822A1 Heteroaryl amines as glycogen synthase kinase 3beta inhibitors (gsk3 inhibitors)
05/08/2003CA2463821A1 Amide derivatives as glycogen synthase kinase 3-beta inhibitors
05/08/2003CA2462206A1 Substituted thioacetamides
05/07/2003EP1308441A1 2-aminopyridine compounds and use thereof as drugs
05/07/2003EP1308438A1 3-substituted urea derivatives and medicinal use thereof
05/07/2003EP1308436A1 Calcium receptor antagonists
05/07/2003EP1307426A1 Amino diphenyl ethers and amido diphenyl ethers
05/07/2003EP1307184A2 Drugs for incontinence
05/07/2003EP1214316B1 Five membered-ring compounds and utilization thereof in liquid crystal mixtures
05/07/2003EP1095036B1 Cinnamic acid derivatives as cell adhesion molecules
05/07/2003EP1019358B1 3,3-diarylpropylamines , their use and preparation
05/07/2003EP0986527B1 Reduction of carbonyl compounds by a silane in the presence of a zinc catalyst
05/07/2003EP0889863B1 Surface modified carbonate materials
05/07/2003EP0749433B1 (4,4-difluorobut-3-enylthio)-substituted heterocyclic or carbocyclic ring compounds having pesticidal activity
05/07/2003CN1416419A 4-aminopicolinates and their use as herbicides
05/07/2003CN1415619A Compound for adjusting functional activity of vascular endothelial cell, its preparation method as well as usage
05/07/2003CN1415618A Compound possessing function for preventing and curing thrombus disease, its pharmacy compsn. and usage in medication
05/07/2003CN1415617A Compound possessing function for preventing and curing atherosclerosis and its application in biologic pharmacological science
05/07/2003CN1415606A Method of preparing compound of 0-substituted sulphonyl propylhomoserin class
05/07/2003CN1107766C Sizing of paper
05/07/2003CN1107503C Optically pure compoun as medicinal use
05/06/2003US6559341 Phthalic acid diamide derivatives, fluorine-containing aniline compounds as starting material, agricultural and horticultural insecticides, and a method for application of the insecticides
05/06/2003US6559310 Aryl borates
05/06/2003US6559170 Pyridine derivatives having fungicidal activity and processes to produce and use same
05/06/2003US6559157 Dihydronaphthalene compounds
05/06/2003US6559140 Cyclic and bicyclic diamino histamine-3 receptor antagonists
05/02/2003EP1306131A2 Cross-Coupling catalyst comprising a cyclic nitrogen ligand and process using the same
05/02/2003EP1305346A2 Transformation of polymers to useful chemicals by oxidation
05/02/2003EP1305319A1 4-phenyl-pyridine derivatives as neurokinin-1 receptor antagonists
05/02/2003EP1305304A1 Carboxamide compounds and their use as antagonists of a human 11cby receptor
05/02/2003EP1305301A1 Alpha-acyl and alpha-heteroatom-substituted benzene acetamide glucokinase activators
05/02/2003EP1305292A1 Biphenyl carboxamides
05/02/2003EP1305289A2 Novel heteroaryl derivatives and use thereof as anti-tumour agents
05/02/2003EP1305288A1 Potassium channel inhibitors
05/02/2003EP1305274A2 Novel c-4 substituted retinoids
05/02/2003EP1305028A2 Antimicrobial biaryl compounds
05/02/2003EP1086103B1 Pyrido 2,3-b]indolizine derivatives and aza analogues thereof; crf 1 specific ligands
05/02/2003EP0999840B1 Use of a draflazine analogue for treating pain
05/02/2003EP0918761B1 Certain amido- and amino-substituted benzylamine derivatives; a new class of neuropeptite y1 specific ligands
05/02/2003EP0910563B1 Integrin receptor antagonists
05/02/2003EP0831799B1 Compounds active at a novel site on receptor-operated calcium channels useful for treatment of neurological disorders
05/02/2003EP0772593B1 Thiopyridyl compounds for controlling helicobacter bacteria
05/01/2003WO2003035627A1 Piperazine derivatives with ccr1 receptor antagonist activity
05/01/2003WO2003035609A1 Zwitterionic imides
05/01/2003WO2003035602A1 Lipid modulators
05/01/2003WO2003035067A1 Novel dipeptidyl peptidase iv (dp-iv) inhibitors as anti-diabetic agents
05/01/2003WO2003035057A1 Inhibitors of dipeptidyl peptidase iv
05/01/2003WO2003034989A2 α-HYDROXYARYLBUTANAMINE INHIBITORS OF ASPARTYL PROTEASE
05/01/2003WO2003006443A3 2- 4-(naphtalin-2-yl)-thiazol-2-ylaminocarbonyl benzoic acid and 2- 4-(naphtalin-2-yl)-pyrimidin-2-ylaminocarbonyl benzoic acid and additional compounds serving as telomerase inhibitors for use in tumor therapy
05/01/2003WO2002102782A3 QUINAZOLINE DERIVATIVES which PROMOTE THE RELEASE OF PARATHYROID_HORMONE
05/01/2003WO2002090352A3 Selective anthranilamide pyridine amides as inhibitors of vegfr-2 and vegfr-3
05/01/2003WO2002083842A3 Small molecule inhibitors of secretion of proteins encoded by are-mrnas
05/01/2003WO2002046249A9 Methods of copolymerizing ethylene and isobutylene and polymers made thereby
05/01/2003WO2002044113A9 Use of(-) (3-halomethylphenoxy) (4-halophenyl) acetic acid derivatives for treatment of insulin resistance, type 2 diabetes, hyperlipidemia and hyperuricemia
05/01/2003WO2002005834A3 Novel uses for thyroid hormones or thyroid hormone-like agonist compounds for treating dermis conditions
05/01/2003US20030083504 N- (4-carbamimidoyl-phenyl) -glycine derivatives
05/01/2003US20030083503 Synthesis of acylated keto amides from sulfonyl amides
1 ... 330 331 332 333 334 335 336 337 338 339 340 341 342 343 344 345 346 347 348 349 350 ... 633